Objective The aim of this study was to develop a radiomics signature for prediction of
progression-free survival (PFS) in lower-grade gliomas and to investigate the genetic …

Simple Summary The non-enhancing peritumoral area (NEPA) is defined as the
hyperintense region in T2-weighted and fluid-attenuated inversion recovery (FLAIR) images …

Hypoxia, a characteristic trait of Glioblastoma (GBM), is known to cause resistance to chemo-
radiation treatment and is linked with poor survival. There is hence an urgent need to non …

The physiologic processes underlying MRI contrast enhancement in glioblastoma patients
remain poorly understood. MRIs of 148 glioblastoma subjects from The Cancer Imaging …

Integrative analyses based on statistically relevant associations between genomics and a
wealth of intermediary phenotypes (such as imaging) provide vital insights into their clinical …

Objective Previous studies on glioblastomas (GBMs) have not reached a consensus on
peritumoral edema (PTE)'s influence on survival. This study evaluated the PTE index's …

The current research in oncology is focused on genetics and molecular oncology in order to
obtain better understanding of the etiology of tumor disease. Detailed knowledge of …

Cancer is a dynamic disease, characterized by a cascade of genomic alterations such as
driver mutations, chromosomal anomalies, and epigenetic alterations; some of which have …

Aims and objectives To compare perfusion characteristics of glioblastomas, measured by
using contrast-enhanced magnetic resonance (MR) perfusion studies, between long-term …

In magnetic resonance imaging (MRI) gadolinium-based contrast agents are administered to
identify areas of blood brain barrier compromise that result in brain tumor enhancement. The …